Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Heptakis(6-bromo-6-deoxy)-β-cyclodextrin reacts with four different polyaminocyclodextrins to form new pH-responsive nanosponges. Also, it exhibits very high binding potentials towards the anesthetic drugs sevoflurane and halothane.